Dikhyaa Mohanty 
A third dose of the Pfizer-BioNTech vaccine is more effective in reducing severe COVID-19 symptoms compared to people who have received two doses as found by a new study.
According to the reports, research which was published in The Lancet Journal stated that individuals who received three doses of Pfizer’s vaccine which is 7 days or more after the third dose had a 92% lower risk of severe COVID-19 attack and 81% lower risk of COVID-related death compared to those who completed two doses five months ago.
Ran Balicer of Clalit Research Institute in Israel stated that the results show convincingly that the third dose of the vaccine is highly effective against severe Covid-19 related outcomes in different age groups and population subgroups, one week after the third dose and these data should facilitate informed policy decision-making.
The report further stated that the research team reviewed data provided by 7,28,321 individuals aged 12 or above who had received the third dose of the BNT162b2 vaccine and it were matched 1:1 with 7,28,321 individuals who received only two shots of the same vaccine at least five months ago.
Picc Courtesy – Google
